Nurix Therapeutics, Inc. (NRIX)
NASDAQ·Healthcare·Biotechnology
$15.16
+2.12%
Mkt Cap $2.81B
Analyst Ratings
Buy
26
Hold
1
Sell
0
Price Target (50 analysts)
$35.27
Range $31.00 – $45.00
Implied Upside
+132.7%
Consensus $35.27 vs current $15.16
NASDAQ·Healthcare·Biotechnology
$15.16
+2.12%
Mkt Cap $2.81B
Buy
26
Hold
1
Sell
0
Price Target (50 analysts)
$35.27
Range $31.00 – $45.00
+132.7%
Consensus $35.27 vs current $15.16